ORMP
Oramed Pharmaceuticals, Inc

4,721
Loading...
Loading...
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Oramed Pharmaceuticals, Inc?
What is the 52-week high for Oramed Pharmaceuticals, Inc?
What is the 52-week low for Oramed Pharmaceuticals, Inc?
What is Oramed Pharmaceuticals, Inc stock price today?
What was Oramed Pharmaceuticals, Inc stock price yesterday?
What is the PE ratio of Oramed Pharmaceuticals, Inc?
What is the Price-to-Book ratio of Oramed Pharmaceuticals, Inc?
What is the 50-day moving average of Oramed Pharmaceuticals, Inc?
How many employess does Oramed Pharmaceuticals, Inc has?

Latest ORMP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.